PS128 recognized with Taipei Biotech Award's International Leap Silver Award益福生醫「精神益生菌PS128」在全球市場布局有成,銷售年年大幅成長,已成功簽約超過44國,終端產品目前已於全球超過28個市場成功上市。益福生醫採取在當地製造、因地制宜的靈活策略,得到歐美各國消費者的信賴,獲評審肯定,拿下2021年台北生技獎「國際躍進獎」銀獎殊榮。...
Combined oxytocin and psychobiotic therapy improves autism symptoms in novel clinical studyTAIPEI, June 15, 2021 /PRNewswire/ A combination of oxytocin and a probiotic could synergistically improve symptoms of autism. These were...
Psychobiotic PS128 improves mood and sleep quality in its first clinical study on anxiety and stressBened Biomedical’s psychobiotic PS128 significantly improved insomnia, stress, and anxiety during a recent clinical trial. Participants...
Taiwan reveals new findings to treat Parkinson's disease19 February 2021 | News In this pioneer study, PS128 was used as adjunct treatment for a group of twenty-five PD patients for three...
Psychobiotic PS128 consumption shows benefits to Parkinson's symptoms in new clinical studyTAIPEI, Feb. 18, 2021 /PRNewswire/ -- Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study...
Psychobiotic PS128 consumption shows benefits to Parkinson's symptoms in new clinical study18 Feburary 2021 | PRNewsWire Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study for its...